Contemplating an interview at the USPTO? Our analysis found that nearly 95% of examiners are more likely to allow an application when an interview is part of the prosecution.
In 2019, the USPTO issued revised § 101 guidance, while the Senate Judiciary Committee Subcommittee on Intellectual Property held a series of high-profile hearings on a legislative proposal to abrogate Alice. Several patent-related bills were also introduced in Congress, including the STRONGER Patents Act and the Inventor Rights Act. As we continue to monitor those developments, we now turn...
Receiving a rejection for a patent application is no one’s idea of a good time. After spending hours on hours shaping a patent application that is focused, novel, and specific, you are told to reconsider your hard work and have another go at it.
We recently identified the ten most difficult examiners currently reviewing applications at the USPTO. Our research prompted the question: “Which firms and companies have prosecuted the most applications in front of these difficult examiners?”
In an update to our 2016, 2017, and 2018 lists of most difficult examiners at the USPTO, we have identified the 10 patent examiners (excluding SPEs) with the most skeptical eye toward the patent applications that cross their desks.
The USPTO recently hosted a webinar about the general approach to interpreting claims and how the specification interacts with and modifies those claims. With the goal of providing answers to common examiner questions, the webinar specifically discussed the importance of the broadest reasonable interpretation (BRI) of each claim, how to handle claim limitations, and the added difficulty of...
United Technologies, an American multinational conglomerate, recently agreed to combine its aerospace business with military contractor Raytheon, creating a new manufacturing giant in the aerospace and defense sectors. Under the new name of Raytheon Technologies, the merged company would have about $74 billion in expected sales for 2019. 
Sprint and T-Mobile recently announced that they had reached a deal to merge, promising to “be a force for positive change in the U.S. wireless, video, and broadband industries.” Combining the country’s third and fourth largest mobile service providers would be one of the most significant consolidations in the American wireless market in years.
Due to inconsistent interpretation, preparing for and responding to Alice rejections has become one of the most stressful aspects of patent prosecution. Rejections citing Alice have multiplied exponentially since the initial decision on June 19, 2014, and they now account for more than 60% of §101 rejections and more than 8% of all rejections, as of our latest analysis.
Two of the biggest pharmaceutical companies are joining forces in a blockbuster merger. Bristol-Myers Squibb is buying Celgene in a cash and stock deal valued at about $74 billion.
1 2

Get to know your competition.

Watch our webinar on using competitive intelligence analytics. 

DOWNLOAD

See how Juristat can transform your patent practice. 

GET A DEMO